The Global Fund to fight AIDS, TB and Malaria (GFATM) policies have evolved to increasingly enable countries to request resources to support viral hepatitis, harm reduction and triple elimination services, with the latest GFATM funding cycle allowing countries to prioritize requests for hepatitis services among people living with HIV (PLHIV), key populations and pregnant women.

Resource Toolkit on GFATM 2023 2025 Funding Opportunity for Hepatitis

Recognizing that the GFATM process involves many stakeholders to evaluate and determine country funding priorities and there are several GFATM documents/policies to navigate, CHAI together with support from partners like the World Hepatitis Alliance, World Health Organization, The Hepatitis Fund and others has developed a Resource Toolkit on GFATM 2023 2025 Funding Opportunity for Hepatitis.

This Toolkit targets to equip a wide range of stakeholders (including, but not limited to, Ministry of Health, partners and civil society) with the intel and tools to understand the GFATM hepatitis-related policies and support advocacy efforts for hepatitis services within this next round of funding requests in 2023. It includes:

• A detailed summary of the evolution of GFATM hepatitis-related policies and specific guidance for this 2023-2025 funding round
• Several Country Case Studies, highlighting countries who have been successful in this process
• Tools to support advocacy and funding requests like the rationale for making hepatitis-related investments, cost-effectiveness rationale, a summary of pricing for HBV and HCV commodities, generic advocacy workplan and activities checklist that can be customized to country settings
• ..and much more!